Skip to main content

Market Overview

28 Stocks Moving In Monday's Mid-Day Session



  • China Lending Corporation (NASDAQ: CLDC) shares gained 166.3 percent to $2.13 after the company earlier reported it is cooperating with Zhejiang Lixin Holding to support a restructuring or sale.
  • India Globalization Capital, Inc. (NYSE: IGC) climbed 38.3 percent to $5.6005 after falling 4.26 percent on Friday.
  • Companhia Energética de Minas Gerais (NYSE: CIG) gained 20.64 percent to $2.63 after climbing 7.92 percent on Friday.
  • Pyxus International, Inc. (NYSE: PYX) surged 14.7 percent to $32.31.
  • Azul S.A. (NYSE: AZUL) rose 14.4 percent to $22.00.
  • Centrais Elétricas Brasileiras S.A. - Eletrobras (NYSE: EBR) shares gained 13.8 percent to $5.53.
  • GOL Linhas Aéreas Inteligentes S.A. (NYSE: GOL) gained 13.3 percent to $7.26. GOL Linhas expects Q3 operating margin of 5.0 percent to 5.5 percent and EBITDA margin of 11.0 percent to 11.5 percent.
  • iFresh Inc. (NASDAQ: IFMK) gained 12.3 percent to $2.38.
  • Banco Santander (Brasil) S.A. (NYSE: BSBR) climbed 10.1 percent to $11.25.
  • Petróleo Brasileiro S.A. - Petrobras (NYSE: PBR) rose 9.9 percent to $15.28 after gaining 1.61 percent on Friday. JP Morgan upgraded Petrobras from Neutral to Overweight.
  • Companhia Paranaense de Energia - COPEL (NYSE: ELP) shares climbed 9.9 percent to $6.79.
  • Banco Bradesco S.A. (NYSE: BBD) shares rose 9.5 percent to $8.755.
  • Itaú Unibanco Holding S.A. (NYSE: ITUB) gained 9.5 percent to $13.38.
  • Kala Pharmaceuticals, Inc. (NASDAQ: KALA) climbed 7.89 percent to $8.34 after falling 2.21 percent on Friday.
  • Medigus Ltd. (NASDAQ: MDGS) rose 5.5 percent to $3.24.
  • Barnes & Noble, Inc. (NYSE: BKS) rose 5.1 percent to $7.305 following Barron's report saying shares could have more upside.


Check out these big penny stock gainers and losers


  • Menlo Therapeutics Inc. (NASDAQ: MNLO) shares tumbled 34.3 percent to $6.675 after the company disclosed that its Phase 2 study of MTI-110 missed primary and secondary endpoints.
  • Altimmune, Inc. (NASDAQ: ALT) shares declined 32.5 percent to $4.89 after the company earlier reported a $25 million registered direct offering at $5.40 per unit. Altimmune presented an oral abstract on its intranasal influenza vaccine NasoVax at the IDWeek conference held in San Francisco over the weekend. The presentation made Oct. 6 showed that NasoVAX was well-tolerated and elicited comparable antibody responses and nearly sixfold higher cellular immune response than Sanofi's Fluzone injectable influenza vaccine.
  • Dogness (International) Corporation (NASDAQ: DOGZ) shares fell 26.4 percent to $1.81.
  • vTv Therapeutics Inc. (NASDAQ: VTVT) dipped 14.1 percent to $2.8787.
  • New Age Beverages Corporation (NASDAQ: NBEV) fell 12.5 percent to $7.41.
  • Aluminum Corporation of China Limited (NYSE: ACH) shares dropped 12.1 percent to $10.61 after rising 2.12 percent on Friday.
  • Glu Mobile Inc. (NASDAQ: GLUU) dipped 10.8 percent to $6.420.
  • Arcturus Therapeutics Ltd. (NASDAQ: ARCT) dropped 9.1 percent to $7.16.
  • iRobot Corporation (NASDAQ: IRBT) fell 9 percent to $96.55. PiperJaffray downgraded iRobot from Overweight to Neutral.
  • Dragon Victory International Limited (NASDAQ: LYL) dropped 7.6 percent to $2.31.
  • Astrotech Corporation (NASDAQ: ASTC) dropped 7.3 percent to $2.42.
  • Vodafone Group Plc (NASDAQ: VOD) fell 3.6 percent to $20.33. Jefferies downgraded Vodafone from Buy to Hold.

Related Articles (ACH + ALT)

View Comments and Join the Discussion!

Posted-In: Losers Mid-Day MoversNews Movers & Shakers Intraday Update Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at